Thomas Englese

Thomas Englese

Corporate Officer/Principal at TONIX PHARMACEUTICALS HOLDING CORP.

Net worth: 9 785 $ as of 2026-08-30

52 year
Health Technology
Consumer Services
Health Services

Profile

Thomas Joseph Englese is Director at Therakos (UK) Ltd. since 2015.
Mr. Englese is Chief Commercial Officer at Tonix Pharmaceuticals Holding Corp.
starting in 2026.
Former roles include Senior Director-Business Operations at Baxter International, Inc. from 2002 to 2008, Vice President-Customer Operations at Ikaria, Inc. from 2008 to 2015, General Manager-North America Hospital Therapies at Keenova Therapeutics Plc from 2015 to 2019, and Chief Commercial Officer at Elutia, Inc. and Tris Pharma, Inc. Education includes an MBA from The Pennsylvania State University in 2002 and an undergraduate degree from Villanova University in 1996.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-09-03 694 ( 0.01% ) 9 785 $ 2026-08-30

Thomas Englese active positions

CompaniesPositionStart
TONIX PHARMACEUTICALS HOLDING CORP. Corporate Officer/Principal 2024-09-09
Director/Board Member 2015-10-29

Former positions of Thomas Englese

CompaniesPositionEnd
MALLINCKRODT PLC Corporate Officer/Principal 2019-06-30
IKARIA, INC. Corporate Officer/Principal 2015-02-28
BAXTER INTERNATIONAL INC. Corporate Officer/Principal 2007-12-31
Corporate Officer/Principal -
ELUTIA INC. Corporate Officer/Principal -
See the detail of Thomas Englese's experience

Training of Thomas Englese

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

92

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Thomas Englese